Wockhardt, a pharmaceutical and biotechnology company, has posted a net loss of Rs.24.98 crore for the first quarter of this fiscal, the company said in a regulatory filing on Monday.
According to the standalone unaudited results submitted to the Bombay Stock Exchange (BSE), the company's profits declined by Rs.19.63 crore in the April-June quarter from a profit of Rs.5.35 crore in Q1 2014-15, a fall of 366 percent in profits.
However, total income from operations rose by Rs.29.26 crore from the last quarter.
Wockhardt clocked Rs.514.7 crore as the total income for Q1 2015-16 compared to Rs.485.44 crore in the same period last year, a rise of six percent.
Wockhardt has 12 manufacturing plants in India, Britain, Ireland and the US and employs 607 scientists in three global research centres.